Cleveland.com: Ventilator shortage during coronavirus? 3-D printing could save lives
UC anesthesiologist discusses ventilators
Imagine printing a three-dimensional piece of plastic that could help save a coronavirus patient’s life. 3-D printing is one solution proposed to address an expected shortage of ventilators, machines that keep patients whose lungs are severely damaged alive. Experts are expecting a shortages of ventilators as the number of people impacted by the coronavirus pandemic grows in the U.S.
Ventilators work through a breathing tube inserted into a person’s windpipe. The machine inflates the lungs with air and then deflates the lungs, removing carbon dioxide. A medical professional uses a computer to control the amount of pressure placed on the lungs and the amount of oxygen.
Coronavirus patients are at risk of pneumonia and acute respiratory distress syndrome, which has a high mortality rate. Dr. Suzanne Bennett, an associate professor at the UC College of Medicine and an anesthesiologist at UC Health, discussed the workings of ventilators.
A traditional ventilator costs about $25,000 to $50,000. Bennett said some of the “bells and whistles" on a hospital-grade ventilator help medical professionals operate the machine effectively, and reduce the workload for respiratory therapists. With a shortage, respiratory therapists would be spread thin.
“I think all of us are concerned with the safety of that patient in that situation,” she said.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.
Is there anything to fear from Hantavirus?
May 12, 2026
The University of Cincinnati's Carl Fichtenbaum, MD, professor of clinical medicine in the Division of Infectious Diseases in the Department of Internal Medicine at the College of Medicine, recently appeared on Scott Sloan's show on 700 WLW to share facts surrounding Hantavirus.